Shanghai OPM Biosciences Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	354.91	296.78	242.69	294.27	212.68
Other Revenue	-	0.47	0.43	0.1	-
Revenue	354.91	297.24	243.12	294.37	212.68
Revenue Growth (YoY)	19.40%	22.26%	-17.41%	38.41%	70.19%
Cost of Revenue	-	142.34	101.53	107.25	86
Gross Profit	354.91	154.9	141.59	187.12	126.69
Selling, General & Admin	-	105.94	74.47	60	50.96
Research & Development	-	33.37	41.91	32.19	19.03
Other Operating Expenses	305.31	2.21	-0.23	1.17	0.78
Operating Expenses	305.31	148.44	122.57	98.11	71.09
Operating Income	49.6	6.46	19.02	89	55.6
Interest Expense	-	-3.12	-3.23	-4.98	-4.79
Interest & Investment Income	-	31.14	36.3	17.98	9.07
Currency Exchange Gain (Loss)	-	2.4	0.87	2.24	-0.24
Other Non Operating Income (Expenses)	-0.23	-0.05	-0.09	-0.14	-0.07
EBT Excluding Unusual Items	49.37	36.84	52.89	104.09	59.57
Gain (Loss) on Sale of Investments	-	4.63	1.53	1.67	-
Gain (Loss) on Sale of Assets	-	0.09	-0.02	0.29	-0.02
Asset Writedown	-	-7.51	-	-	-
Other Unusual Items	-	2.38	7.26	13.38	8.61
Pretax Income	49.37	36.43	61.67	119.43	68.15
Income Tax Expense	7.67	16.19	8.41	14.06	7.76
Earnings From Continuing Operations	41.7	20.24	53.26	105.37	60.39
Minority Interest in Earnings	-	0.82	0.78	-	-
Net Income	41.7	21.05	54.04	105.37	60.39
Net Income to Common	41.7	21.05	54.04	105.37	60.39
Net Income Growth	98.07%	-61.04%	-48.72%	74.47%	416.87%
Shares Outstanding (Basic)	113	111	115	101	86
Shares Outstanding (Diluted)	113	117	115	101	86
Shares Change (YoY)	-3.64%	1.72%	13.48%	17.43%	0.20%
EPS (Basic)	0.37	0.19	0.47	1.04	0.70
EPS (Diluted)	0.37	0.18	0.47	1.04	0.70
EPS Growth	105.56%	-61.70%	-54.81%	48.57%	415.84%
Free Cash Flow	-	-51.61	-19.59	-35.34	8.64
Free Cash Flow Per Share	-	-0.44	-0.17	-0.35	0.10
Dividend Per Share	-	0.420	0.440	0.429	-
Dividend Growth	-	-4.47%	2.66%	-	-
Gross Margin	100.00%	52.11%	58.24%	63.57%	59.56%
Operating Margin	13.98%	2.17%	7.82%	30.23%	26.14%
Profit Margin	11.75%	7.08%	22.23%	35.80%	28.40%
Free Cash Flow Margin	-	-17.36%	-8.06%	-12.01%	4.06%
EBITDA	85.36	42.22	47.04	113.28	74.34
EBITDA Margin	24.05%	14.21%	19.35%	38.48%	34.96%
D&A For EBITDA	35.76	35.76	28.02	24.28	18.74
EBIT	49.6	6.46	19.02	89	55.6
EBIT Margin	13.98%	2.17%	7.82%	30.23%	26.14%
Effective Tax Rate	15.54%	44.45%	13.63%	11.78%	11.39%
Revenue as Reported	-	297.24	243.12	294.37	212.68
Advertising Expenses	-	2.08	2.29	1.34	0.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.